EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,502 JPY | +0.37% |
|
-1.37% | -7.80% |
| 02/07 | Eli Lilly Alzheimer's drug approved by US FDA | RE |
| 02/07 | Eisai Repurchases 4.8 Billion Yen Worth of Shares in June | MT |
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
02/08/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
6,502
JPY
Average target price
8,040
JPY
Spread / Average Target
+23.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.80% | 11.52B | |
| +57.13% | 823B | |
| -7.20% | 353B | |
| +15.19% | 320B | |
| +7.61% | 295B | |
| +13.62% | 239B | |
| +14.55% | 220B | |
| -0.33% | 219B | |
| +8.14% | 167B | |
| -3.18% | 159B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Jefferies Adjusts Eisai’s Price Target to 6,300 Yen From 7,500 Yen, Keeps at Hold
